Results 31 to 40 of about 161 (131)

Montelukast Versus Gabapentin for Uremic Pruritus in Twice‐Weekly Hemodialysis Patients: A 52‐Week Prospective Non‐Randomized Open‐Label Comparative Study

open access: yesHemodialysis International, EarlyView.
ABSTRACT Background Uremic pruritus (UP) remains a common and distressing complication in patients with end‐stage renal disease (ESRD) receiving maintenance hemodialysis. The burden is particularly pronounced in low‐ and middle‐income countries where twice‐weekly hemodialysis is frequently practiced because of resource limitations. Gabapentin is widely
Bilal Mohsin   +9 more
wiley   +1 more source

Real‐world effects of beremagene geperpavec in epidermolysis bullosa

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
This real‐world German study evaluates beremagene geperpavec (B‐VEC) in 38 patients with dystrophic epidermolysis bullosa. It shows multidimensional improvements in wound healing, patient‐reported outcomes and systemic markers. Response varies with host factors like BMI, inflammation and co‐therapies, while baseline autoantibodies do not predict ...
Meropi Karakioulaki   +12 more
wiley   +1 more source

Preclinical and human surrogate models of itch

open access: yes, 2016
Pruritus, or simply itch, is a debilitating symptom that significantly decreases the quality of life in a wide range of clinical conditions. While histamine remains the most studied mediator of itch in humans, treatment options for chronic itch, in ...
Arendt-Nielsen, Lars   +9 more
core   +1 more source

Evaluation of the plant glucoside monoterpene indole alkaloid brachycerine for potential protection of human skin against ultraviolet damage

open access: yesPhotochemistry and Photobiology, EarlyView.
The antioxidant plant alkaloid brachycerine can protect human skin from UV‐A and UV‐B induced damage. Skin pre‐treated with alkaloid and exposed to UV showed preserved nerve endings and no DNA damage. ROS = reactive oxygen species; green blunt arrow = inhibition; purple arrows = UV; red arrow: damage. Abstract Sunlight ultraviolet radiation A and B (UV‐
Naíla Cannes do Nascimento   +9 more
wiley   +1 more source

Evaluation of Two Induction Protocols for Oclacitinib in Dogs

open access: yesVeterinary Dermatology, EarlyView.
Background: Oclacitinib is approved for the treatment of canine atopic dermatitis and pruritus. The conventional administration protocol includes twice‐daily oral dosing for 14 days with a subsequent reduction to once‐daily administration. This reduction sometimes leads to an increase in pruritus.
Paulina J. C. Popp   +5 more
wiley   +1 more source

Mutations in Myosin 5B in Children With Early-onset Cholestasis

open access: yes, 2020
OBJECTIVES: Mutations in Myosin 5B (MYO5B) are known to be associated with microvillous inclusion disease (MVID) a genetic cause of neonatal intractable diarrhoea.
Elena Kontaki   +27 more
core   +1 more source

Effects of a Dietary Supplementation of Bovine Colostrum in Dogs With Atopic Dermatitis

open access: yesVeterinary Dermatology, EarlyView.
ABSTRACT Background Bovine colostrum (BC) shows immunomodulatory properties, which could be beneficial in the management of chronic immune‐mediated diseases such as canine atopic dermatitis (cAD). Objective To assess if a BC supplementation affects selected immune variables and clinical signs in cAD.
Laura Schäfer   +2 more
wiley   +1 more source

Efficacy of Oral Lotilaner in Controlling Clinical Signs in Cats Naturally Infested With Lynxacarus radovskyi

open access: yesVeterinary Dermatology, EarlyView.
Background: Lynxacarus radovskyi is a pilicolous mite that may cause pruritus and coat or skin lesions in cats. Evidence regarding the efficacy of oral lotilaner for the treatment of feline lynxacariasis remains limited. Hypothesis/Objectives: To evaluate the parasitological and clinical efficacy of oral lotilaner in cats naturally infested with L ...
Yasmin da Mota de Magalhães   +4 more
wiley   +1 more source

Swiss Practice Recommendations for Chronic Prurigo Including Prurigo Nodularis

open access: yesInternational Journal of Dermatology, Volume 65, Issue 12, Page 2497-2508, December 2026.
Chronic prurigo, including prurigo nodularis, is a chronic, often treatment‐refractory condition characterized by persistent pruritus and chronic scratch lesions. Advances in the understanding of its underlying pathophysiology have enabled the development of novel targeted therapies; however, management remains challenging due to the expanding range of
Simon M. Mueller   +11 more
wiley   +1 more source

The prevalence and clinical characteristics of pruritus among patients with extensive psoriasis

open access: yes, 2000
Many patients with psoriasis are known to suffer from itch. However, the data available regarding itch and its characteristics in psoriasis are sparse.
Chan, Y H   +9 more
core   +1 more source

Home - About - Disclaimer - Privacy